During the past decade, Military Hospital of Tunis conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Military Hospital of Tunis" #1 sponsor was "Military Hospital of Tunis" with 6 trials, followed by "General Administration of Military Health, Tunisia" with 4 trials sponsored, "Celgene" with 2 trials sponsored, "Laboratoire français de Fractionnement et de Biotechnologies" with 2 trials sponsored and "Oystershell NV" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Military Hospital of Tunis" #1 collaborator was "Dacima Consulting" with 2 trials as a collaborator, "UR17DN02 : Autoimmune Diseases Research Unit" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "B. Braun Medical International Trading Company Ltd." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Military Hospital of Tunis" are "Septic Shock" (4 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Behçet Disease" (1 trials), "Beta-Thalassemia" (1 trials) and "Beta-thalassemia" (1 trials). Many other conditions were trialed in "Military Hospital of Tunis" in a lesser frequency.

Most popular intervention types in "Military Hospital of Tunis" are "Drug" (11 trials), "Device" (8 trials), "Other" (4 trials), "Diagnostic Test" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "I10E" (2 trials), "Loceryl 5%" (2 trials), "Luspatercept" (2 trials), "Microdialysis Probe (Muscle microdialysis)" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Military Hospital of Tunis" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Military Hospital of Tunis". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Military Hospital of Tunis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Military Hospital of Tunis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".